维普中文期刊产品整合服务
22篇 您的检索式:作者名="Tulliez M"
    题名 作者 年代 出处 被引量
1JAK2V617Fexpression inmurine hematopoietic cells leads to MPD mimicking human PVwith secondary myelofibrosis显示文摘Lacout C Pisani DF Tulliez M 2006Blood2006,108,:1
2A non-randomised dose-escalating phase Ⅱ study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Francais des Mye1odysplasies 显示文摘Bouscary D Legros L Tulliez M 2005British Journal of Haematology2005,131,5:1
3JAK2V617F expression in murine hematopoietie cells leads to MPD mimicking human PV with secondary myelofibrosis 显示文摘Lacout C Pisani DF Tulliez M 2006Blood2006,108,5:1
4Effects of octreotide treatment on early TNF2 production and localization in experimental chronic colitis显示文摘Lamrani A Tulliez M Chauvelot-Moachon L 1999Aliment Pharmacol Ther1999,13,5:1
5Pseudouveitis: a clue to the diagnosis of primary central nervous system lymphoma in immunocompetent patients显示文摘PARK S ABAD S TULLIEZ M 2004Medicine (Baltimore)2004,83,4:1
6High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice显示文摘Villeval JL Cohen-Solal K Tulliez M 1997Blood1997,90,11:1
7Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice显示文摘Chagraoui H Komura E Tulliez M 2002Blood2002,100,10:1
8High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice显示文摘Villeval JL Cohen - Solal K Tulliez M 1997Blood1997,90,11:1
9A non-randomised doseescalating phase Ⅱ study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: The Thal-SMD-2000 trial of the Groupe Francais des Myelodysplasies 显示文摘Bouscary D Legros L Tulliez M 2005Br J Haematol2005,131,609:1
10The Superoxide Dismutase Mime Tic Mn-TBAP Prevents Fas-Induced Acute Liver Failure in the Mouse显示文摘Tulliez M Bedda S Trebeden H 0,,:1
11JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary mye-lofibrosis显示文摘Lacout C Pisani DF Tulliez M 0,,05:1
12JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis 显示文摘Lacout C Pisani D F Tulliez M 2006Blood2006,108,:1
13JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis显示文摘Lacout C Pisani DF Tulliez M 0,,05:1
14A non-randomised doseescalating phase II study of thalidomide for the treat- ment of patients with low-risk myelodysplastic syn dromes:the Tha I SMD-2000 trial of the Group Franais des Myelodys ptasies 显示文摘Bouseary D Legros L Tulliez M 2005Br J H aematol2005,131,5:1
15Prominent role of TGF-β1 in thrombopoietin-induced myelofibrosis in mice显示文摘Chagraoui H Komura E Tulliez M 2002Blood2002,100,10:1
16A non-random iseddose-escalating phase II study of thalidom idle for the treatment of patients with low-risk myelodysplastic syndromes the Thal-SMD-2000 trial of the Group Francais des Mye lodysplasies显示文摘BOUSCARY D LEGROS I TULLIEZ M 2005Br J Haeatol2005,131,:1
17Peritoneal mesothelioma revealed by episodes of recurrent spontaneous peritonitis 显示文摘Fayemendy L Tulliez M Uzzan E 1996Gastroenterol Clin Biol1996,20,1:1
18JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis 显示文摘Lacout C Pisani DF Tulliez M 2006Blood2006,108,5:1
19Detoxifi cation of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse显示文摘 Hammoud R Tulliez M 2001Hepatology2001,33,:1
20A non-randomized doseescalating phaseⅡ study of thalidomide for the treat-ment of patients with low -risk myelodysplastic syn-dromes:the Tha I SMD-2000 trial of the Group Franais-des Myelodys ptasies显示文摘Bouscary D Legros I Tulliez M 0,,05:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费